Human PD - L1 inhibitor V

Description:

Human PD-L1 inhibitor V is a peptide-based molecule. It binds to human PD-1 and inhibits PD-1/PD-L1 binding.

Sequence:

LDYVNRRKMYQ

General

References

Comments (0)

Name	Human PD - L1 inhibitor V
Category	Cancer Research Peptides
One Letter Code	LDYVNRRKMYQ
Three Letter Code	{Leu}{Asp}{Tyr}{Val}{Asn}{Arg}{Arg}{Lys}{Met}{Tyr}{Gln}
Molecular Weight	1485.800
Application	Cancer Research

Bardhan, Kankana, Theodora Anagnostou, and Vassiliki A. Boussiotis. "The PD1: PD-L1/2 pathway from discovery to clinical implementation." Frontiers in immunology 7 (2016): 550.

Li, Qiao, et al. "Discovery of peptide inhibitors targeting human programmed death 1 (PD-1) receptor." Oncotarget 7.40 (2016): 64967.

D’Errico, Gabriele, Heather L. Machado, and Bruno Sainz. "A current perspective on cancer immune therapy: step-by-step approach to constructing the magic bullet." Clinical and translational medicine 6.1 (2017): 1-10.